Sana Biotechnology, Inc. (SANA) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts SANA Hot Sheet
Join SI Premium – FREE
Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Alphabet to replace Verizon in the Dow Jones Industrial Average
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
